Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven A Narod

Showing results (201-210 of 544) with videos related to

Pageof 55
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 2, 2016
Effect of decision aid for breast cancer prevention on decisional conflict in women with a BRCA1 or BRCA2 mutation: a multisite, randomized, controlled trialKelly A Metcalfe, Cindy-Lee Dennis, Aletta Poll, et al.
Gynecologic Oncology|June 24, 2010
Prevalence of BRCA1 and BRCA2 germ line mutations among women with carcinoma of the fallopian tubeDanielle Vicus, Amy Finch, Ilana Cass, et al.
Familial Cancer|September 16, 2016
Frequency of germline PALB2 mutations among women with epithelial ovarian cancerJoanne Kotsopoulos, Victoria Sopik, Barry Rosen, et al.
Gynecologic Oncology|June 21, 2012
Height, weight, BMI and ovarian cancer survivalJoanne Kotsopoulos, Joel R K Moody, Isabel Fan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
Genome-wide loss of heterozygosity and uniparental disomy in BRCA1/2-associated ovarian carcinomasChristine S Walsh, Seishi Ogawa, Daniel R Scoles, et al.
Cancer|April 22, 2011
Diabetes and breast cancer among women with BRCA1 and BRCA2 mutationsLouise Bordeleau, Lorraine Lipscombe, Jan Lubinski, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2003
Breast cancer risk reduction associated with the RAD51 polymorphism among carriers of the BRCA1 5382insC mutation in PolandAnna Jakubowska, Steven A Narod, David E Goldgar, et al.
Journal of Medical Genetics|October 4, 2011
Clinical impact of unclassified variants of the BRCA1 and BRCA2 genesMohammad R Akbari, Shiyu Zhang, Isabel Fan, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|December 16, 2020
The impacts of neoadjuvant chemotherapy and of cytoreductive surgery on 10-year survival from advanced ovarian cancerSoyoun Rachel Kim, Joanne Kotsopoulos, Ping Sun, et al.
Cancer Medicine|August 21, 2023
Theory-based behavior change intervention to increase uptake of risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 pathogenic variant: The PREVENT randomized controlled trialKelly A Metcalfe, Tuya Pal, Steven A Narod, et al.
Pageof 55

Showing results (201-210 of 544) with videos related to

Sort By:
Pageof 55
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 2, 2016
Effect of decision aid for breast cancer prevention on decisional conflict in women with a BRCA1 or BRCA2 mutation: a multisite, randomized, controlled trialKelly A Metcalfe, Cindy-Lee Dennis, Aletta Poll, et al.
Gynecologic Oncology|June 24, 2010
Prevalence of BRCA1 and BRCA2 germ line mutations among women with carcinoma of the fallopian tubeDanielle Vicus, Amy Finch, Ilana Cass, et al.
Familial Cancer|September 16, 2016
Frequency of germline PALB2 mutations among women with epithelial ovarian cancerJoanne Kotsopoulos, Victoria Sopik, Barry Rosen, et al.
Gynecologic Oncology|June 21, 2012
Height, weight, BMI and ovarian cancer survivalJoanne Kotsopoulos, Joel R K Moody, Isabel Fan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
Genome-wide loss of heterozygosity and uniparental disomy in BRCA1/2-associated ovarian carcinomasChristine S Walsh, Seishi Ogawa, Daniel R Scoles, et al.
Cancer|April 22, 2011
Diabetes and breast cancer among women with BRCA1 and BRCA2 mutationsLouise Bordeleau, Lorraine Lipscombe, Jan Lubinski, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2003
Breast cancer risk reduction associated with the RAD51 polymorphism among carriers of the BRCA1 5382insC mutation in PolandAnna Jakubowska, Steven A Narod, David E Goldgar, et al.
Journal of Medical Genetics|October 4, 2011
Clinical impact of unclassified variants of the BRCA1 and BRCA2 genesMohammad R Akbari, Shiyu Zhang, Isabel Fan, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|December 16, 2020
The impacts of neoadjuvant chemotherapy and of cytoreductive surgery on 10-year survival from advanced ovarian cancerSoyoun Rachel Kim, Joanne Kotsopoulos, Ping Sun, et al.
Cancer Medicine|August 21, 2023
Theory-based behavior change intervention to increase uptake of risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 pathogenic variant: The PREVENT randomized controlled trialKelly A Metcalfe, Tuya Pal, Steven A Narod, et al.
Pageof 55